Overview
Minal Shah is a Hematologist Oncology specialist and a Hematologist in California, Maryland. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma. Dr. Shah is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
22590 Shady Ct, California, MD 20619
23415 Three Notch Rd, Suite 2051, California, MD 20619
24035 Three Notch Rd, Hollywood, MD 20636
10 Saint Patricks Dr, Waldorf, MD 20603
25500 Point Lookout Rd, Leonardtown, MD 20650
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Medstar Medical Group Ii LLC
Michael Atkins is an Oncologist in Washington, Washington, D.c.. Dr. Atkins is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Melanoma, WT1-Related Wilms Tumor Syndromes, Pancreaticoduodenectomy, and Nephrectomy.
Inova Health Care Services
Jeanny Aragon-Ching is an Oncologist and a Hematologist in Alexandria, Virginia. Dr. Aragon-Ching is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Prostate Cancer, Urothelial Cancer, Bladder Cancer, Orchiectomy, and Prostatectomy. Dr. Aragon-Ching is currently accepting new patients.
Sibley Memorial Hospital
Dr. Mark Markowski is a medical oncologist at the Kimmel Cancer Center at Sibley Memorial Hospital, as well as an Associate Professor in the Department of Oncology at Johns Hopkins University School of Medicine. Dr. Markowski participates in multidisciplinary clinics at Sibley and The Johns Hopkins Hospital, and sees patients in the genitourinary clinics of both hospitals. Dr. Markowski treats numerous types of cancers, with a specialty in prostate and kidney cancers. Dr. Markowski earned his medical degree and Ph.D. in tumor biology at Georgetown University School of Medicine. He completed a residency in internal medicine at Columbia University, followed by a medical oncology fellowship at Johns Hopkins Hospital. Dr. Markowski previously served as a research associate at the Lombardi Comprehensive Cancer Center at Georgetown University. His research interests focus on early phase drug development for prostate cancer, as well a non-castrating therapies for patients with metastatic disease. Dr. Markowski is currently conducting research with funding from a Department of Defense Prostate Cancer Research Program Award and a Challenge Award from the Prostate Cancer Foundation, which focuses on new treatment strategies for prostate cancer patients. Dr. Markowski is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Hormone Replacement Therapy (HRT), and Prostatectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Colorectal CancerDr. Shah isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Shah isDistinguished. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Shah isDistinguished. Learn about Familial Pancreatic Cancer.
- Inflammatory Breast CancerDr. Shah isDistinguished. Learn about Inflammatory Breast Cancer.
- Lung CancerDr. Shah isDistinguished. Learn about Lung Cancer.
- Paget Disease of the BreastDr. Shah isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Acute Mountain SicknessDr. Shah isAdvanced. Learn about Acute Mountain Sickness.
- ALK-Positive Non-Small Cell Lung Cancer
- AnemiaDr. Shah isAdvanced. Learn about Anemia.
- AngiosarcomaDr. Shah isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Shah isAdvanced. Learn about Breast Cancer.
- Childhood Iron Deficiency Anemia
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Shah isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adenoid Cystic CarcinomaDr. Shah isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adult Soft Tissue SarcomaDr. Shah isExperienced. Learn about Adult Soft Tissue Sarcoma.